Good to Go?

FDA Reviews Weight-Loss Drug That May Help Treat Type 2s

| Jul 1, 2001

May 22, the U.S. Food and Drug Administration announced that it will review the weight-loss drug orlistat (Xenical) to determine if it is a suitable treatment for type 2 diabetes. If given FDA approval, Xenical, which works by preventing about one-third of the fat in the food consumed from being absorbed, will be the first weight-loss drug indicated for the treatment of type 2 diabetes.

Xenical maker Roche submitted a supplemental new-drug application to the FDA on March 19, requesting approval of Xenical for the treatment of diabetes based on the results of new clinical trials conducted in overweight and obese patients with type 2 diabetes.

"The clinical trial data show that patients treated with Xenical plus a mildly reduced calorie diet lost more weight than those patients treated with placebo plus diet, and also had significantly greater and sustained decreases in (HbA1c) and fasting plasma glucose," read a May 22 Roche statement. "In addition, patients with type 2 diabetes treated with Xenical were able to reduce their daily doses of sulfonylureas, insulin and [Glucophage]."

In seven large, multi-center, randomized, placebo-controlled trials involving 2,600 patients with type 2 diabetes, Xenical demonstrated:

  • clinically significant improvements in blood-sugar control
  • an ability to aid type 2s in reducing the dose of, or even discontinue, their anti-diabetic medications
  • a weight loss of up to three times more weight than diet alone in overweight and obese patients with type 2 diabetes
  • an improvement in certain risk factors for cardiovascular disease, such as total cholesterol levels and blood pressure.

In addition, Xenical's notorious gastrointestinal side effects, which include gas with oily discharge and increased bowel movements—including an urgent need to have them and an inability to control them—occurred less often among Xenical patients with type 2 diabetes. Also, Xenical's inhibiting effect on the absorption of some vitamins was also observed less frequently in people with type 2 diabetes.

Xenical received FDA approval for the treatment of obesity, including weight loss and weight management, in April 1999. The FDA also cleared Xenical for use in reducing the risk of regaining weight.

Click Here To View Or Post Comments

Categories: A1c Test, Diabetes, Diabetes, Food, Insulin, Type 2 Issues, Weight Loss


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Jul 1, 2001

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.